Student Well-Being

Firm Moves Closer To Brain-Imaging Test for ADHD

By Darcia Harris Bowman — March 28, 2001 2 min read
  • Save to favorites
  • Print

A Boston company is nearing the final phase of testing a diagnostic drug that could offer health-care providers a long-awaited medical test for attention deficit hyperactivity disorder.

Boston Life Sciences Inc. announced this month that its product Altropane was successful in identifying adults who had been clinically diagnosed with long- standing ADHD by mapping the level of certain chemicals in their brain.

ADHD is the most commonly diagnosed behavioral disorder in American children, affecting an estimated 2 million school-age youngsters, according to the National Institutes of Health. Characterized by hyperactivity, short attention spans, and impulsivity, the condition often interferes with a child’s education.

No biological test for diagnosing ADHD is currently available, a situation that some experts contend has led to the misdiagnosis and unnecessary medication of many children. Currently, psychiatrists often rely heavily on reports from parents and educators about children’s behavior in making a diagnosis.

Researchers working on the development of Altropane say their study has shown abnormally high levels of the neurotransmitter dopamine in the brains of people with ADHD, which means a medical diagnosis may not be far away.

“Because of the national controversy presently surrounding the confusion and inconsistencies in the clinical diagnosis of ADHD, and the growing concern over the abuse of stimulant medications by schoolchildren, we believe that the need for an objective, biologically based diagnosis for ADHD has never been greater, nor more urgent for society,” Marc Lanser, Boston Life Science’s chief scientific officer, said in a written statement.

Under guidelines set by the U.S. Food and Drug Administration, the company conducted the first test of its imaging product in 1999 on 10 adult volunteers, six with ADHD, and increased the number of test subjects to 40 for the second phase. The results of the first study were published in The Lancet, a London-based journal of medicine.

The third and final trial of Altropane is to begin this summer with 100 adult test subjects.

Once the testing is wrapped up, Boston Life Sciences will apply to the FDA for fast-track approval to market the product, said Maria Zapf, the company’s manager of corporate affairs.

“Hopefully, this kind of product will quell a little of the controversy over whether ADHD is an actual disorder,” Ms. Zapf said.


Coverage of research is underwritten in part by a grant from the Spencer Foundation.

Related Tags:

A version of this article appeared in the March 28, 2001 edition of Education Week as Firm Moves Closer To Brain-Imaging Test for ADHD

Events

This content is provided by our sponsor. It is not written by and does not necessarily reflect the views of Education Week's editorial staff.
Sponsor
Professional Development Webinar
Inside PLCs: Proven Strategies from K-12 Leaders
Join an expert panel to explore strategies for building collaborative PLCs, overcoming common challenges, and using data effectively.
Content provided by Otus
This content is provided by our sponsor. It is not written by and does not necessarily reflect the views of Education Week's editorial staff.
Sponsor
Science Webinar
Making Science Stick: The Engaging Power of Hands-On Learning
How can you make science class the highlight of your students’ day while
achieving learning outcomes? Find out in this session.
Content provided by LEGO Education
Teaching Profession Key Insights to Elevate and Inspire Today’s Teachers
Join this free half day virtual event to energize your teaching and cultivate a positive learning experience for students.

EdWeek Top School Jobs

Teacher Jobs
Search over ten thousand teaching jobs nationwide — elementary, middle, high school and more.
View Jobs
Principal Jobs
Find hundreds of jobs for principals, assistant principals, and other school leadership roles.
View Jobs
Administrator Jobs
Over a thousand district-level jobs: superintendents, directors, more.
View Jobs
Support Staff Jobs
Search thousands of jobs, from paraprofessionals to counselors and more.
View Jobs

Read Next

Student Well-Being Q&A This School Counselor Has a Four-Legged Trick for Getting Tweens to Open Up
The 2025 School Counselor of the Year supports hundreds of middle schoolers with help from her therapy dog, Winston.
5 min read
Carmen Larson, 2025 School Counselor of the Year.
Carmen Larson, 2025 School Counselor of the Year.
Courtesy of the American School Counselor Association
Student Well-Being Opinion Generation Alpha Is Defined by Tragedy
Rising teens have direct digital access to unending pain, violence, and loss, writes Bettina L. Love.
3 min read
Digital art painting of girl looking at a glowing screen, acrylic on canvas texture, storytelling illustration
iStock/Getty Images + Education Week
Student Well-Being From Our Research Center Are Students Vaping More? Educators Think So
Teachers, principals, and district leaders are reporting an increase despite previous federal data showing teen vaping is declining.
3 min read
Student Well-Being Boys Want a Strong Relationship With Their Teachers. That Doesn't Always Happen
The key to inspiring boys in the classroom is a strong student-teacher relationship, experts say. Here's how to make it work.
7 min read
Jon Becker, upper school history and English teacher, has 9th grader Demetrios Karavedas stand on a chair and apologize for forgetting his book during their 9th grade English class at Boys’ Latin School of Maryland on Oct. 24, 2024 in Baltimore, Md.
Jon Becker, a history and English teacher at Boys' Latin School of Maryland in Baltimore, has 9th grader Demetrios Karavedas stand on a chair and apologize for forgetting his book on Oct. 24, 2024. Positive relationships with teachers matter for boys' academic motivation and success.
Jaclyn Borowski/Education Week